Ansamitocin P-3' (D-tartrate) is a drug for the

is a drug for the amelioration of transthyretin-related hereditary amyloidosis (also familial amyloid polyneuropathy

Annette Säfholm

Daxas was approved in the EU for severe COPD associated with chronic bronchitis

BG45 alone and in combination with bortezomib triggers significant tumor growth inhibition in vivo in a murine xenograft model of human MM

Na/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4

Ansamitocin P-3' (D-tartrate) is a drug for theAnsamitocin P3' is an isomer of Ansamitocin P 3 or iso Ansamitocin P 3 , is a natural product. Ansamitocin P 3' showed potential antineoplastic and antimitotic activity. Ansamitocin ' binds to tubulin and inhibits vinblastine induced spiral formation. Product information CAS Number: 66547 09 9 Molecular Weight: 635. 14 Formula: C32H43ClN2O9 Synonym: Maytansinol butyrate C15003P3 Chemical Name: (1S, 2R, 3S, 5S, 6S, 20R, 21S) 11 chloro 21 hydroxy 12, 20